Ad is loading...
CWGFX
Price
$68.00
Change
+$0.23 (+0.34%)
Updated
Nov 22 closing price
MVGAX
Price
$18.25
Change
+$0.08 (+0.44%)
Updated
Nov 22 closing price
Ad is loading...

CWGFX vs MVGAX

Header iconCWGFX vs MVGAX Comparison
Open Charts CWGFX vs MVGAXBanner chart's image
American Funds Capital World Gr&Inc F1
Price$68.00
Change+$0.23 (+0.34%)
VolumeN/A
CapitalizationN/A
MFS Low Volatility Global Equity A
Price$18.25
Change+$0.08 (+0.44%)
VolumeN/A
CapitalizationN/A
CWGFX vs MVGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGFX vs. MVGAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGFX is a StrongBuy and MVGAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CWGFX has more cash in the bank: 126B vs. MVGAX (275M). CWGFX pays higher dividends than MVGAX: CWGFX (1.64) vs MVGAX (1.10). CWGFX was incepted earlier than MVGAX: CWGFX (24 years) vs MVGAX (11 years). CWGFX is a more actively managed with annual turnover of: 27.00 vs. MVGAX (25.00). CWGFX has a lower initial minimum investment than MVGAX: CWGFX (250) vs MVGAX (1000). MVGAX annual gain was more profitable for investors over the last year : 20.17 vs. CWGFX (19.17). CWGFX return over 5 years is better than : 41.11 vs. MVGAX (34.48).
CWGFXMVGAXCWGFX / MVGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years11 years-
Gain YTD14.66316.07691%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets126B275M45,818%
Annual Yield % from dividends1.641.10149%
Returns for 1 year19.1720.1795%
Returns for 3 years6.279.3967%
Returns for 5 years41.1134.48119%
Returns for 10 years50.2779.9963%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOFX15.580.37
+2.43%
Royce Small-Cap Opportunity Svc
ACGQX24.610.25
+1.03%
Invesco Growth and Income R5
MEFIX12.790.04
+0.31%
Martin Currie Emerging Markets FI
MSEEX21.100.03
+0.14%
Morgan Stanley Europe Opportunity C
MDNAF1.06N/A
-0.33%
Medicenna Therapeutics Corp.